Table 2 DMARD usage at ARAD enrolment (n = 4140)
From: Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study
| Â | Number | Percentage |
|---|---|---|
Biologic use | ||
 Never taken | 1525 | 36.8 |
 Currently taking anti-TNF biologics | 2350 | 56.8 |
 Currently taking other biologics | 128 | 3.1 |
  Abatacept | 32 | 0.8 |
  Anakinra | 7 | 0.2 |
  Rituximab | 66 | 1.6 |
  Tocilizumab | 23 | 0.6 |
 Previous use | 121 | 2.9 |
 Unknowna | 16 | 0.4 |
Methotrexate status | ||
 Never taken | 977 | 23.6 |
 Currently taking | 2302 | 55.6 |
 Stopped taking | 856 | 20.7 |
 Unknowna | 5 | 0.1 |
Prednisone/prednisolone status | ||
 Never taken | 1529 | 36.9 |
 Currently taking | 1613 | 39.0 |
 Stopped taking | 969 | 23.4 |
 Unknowna | 29 | 0.7 |
NSAID status | ||
 Not currently taking | 2011 | 48.6 |
 Currently taking | 2129 | 51.4 |